Fresh Recalls

FDAClass II · Drug · Recall D-0852-2026 · Recalled September 23, 2026

Chlorthalidone Tablets recall — Inventia Healthcare Limited

Agency report date: September 23, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Chlorthalidone Tablets
Company / brand
Inventia Healthcare
Lot / serial / date codes
Batch # RISA24002; Exp Date: 04/2027
Distribution
U.S. Nationwide
Agency product description and boundaries

Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Failed Dissolution Specifications

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Chlorthalidone Tablets recall status

3. Open the official notice or contact

Official recall ID
D-0852-2026
Brand
All Inventia Healthcare recalls
Classification
Class II
Units affected
13567 bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Kalyan, N/A, India
Firm address
Additional Ambernath Midc, Ambernath East; F1-F1/1-F75/1, N/A

Identifying details (verbatim from the notice)

Product codes / lots
Batch # RISA24002; Exp Date: 04/2027
Distribution
U.S. Nationwide
Firm notified the public via
Letter
FDA event ID
99806
Recall initiated
September 3, 2026
FDA classified
September 17, 2026
FDA report date
September 23, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 12:00 PM UTC. Record retrieved October 22, 2026 at 12:00 PM UTC.

Report a data error on this page